Singular Health Group (ASX:SHG) ROE % Adjusted to Book Value: -6.96% (As of Dec. 2025)


ASX:SHG Singular Health Group Ltd ASX:SHG
30 GF Score
Price A$0.20
GF Value A$0.11
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Singular Health Group ROE % Adjusted to Book Value?

Singular Health Group ASX:SHG -9.09% 30 ROE % Adjusted to Book Value is -6.96% as of Dec. 2025. GuruFocus rates ASX:SHG with a GF Score™ of 30/100 and a GF Value™ of A$0.11 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Singular Health Group's ROE % for the quarter that ended in Dec. 2025 was -47.93%. Singular Health Group's PB Ratio for the quarter that ended in Dec. 2025 was 6.89. Singular Health Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -6.96%.


Singular Health Group ROE % Adjusted to Book Value Related Terms


Singular Health Group ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Singular Health Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singular Health Group ROE % Adjusted to Book Value Chart

Singular Health Group Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
ROE % Adjusted to Book Value
-13.85 -31.02 -25.67 -40.57 -10.20

Singular Health Group Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -77.22 -10.37 -11.59 -6.96

ASX:SHG vs VEEV, BTSG, TEM: ROE % Adjusted to Book Value Comparison

For the Health Information Services subindustry, Singular Health Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Singular Health Group ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singular Health Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Singular Health Group's ROE % Adjusted to Book Value falls into.


ASX:SHG
30GF Score
Singular Health Group Ltd ASX:SHG
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Singular Health Group ROE % Adjusted to Book Value Calculation

Singular Health Group's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-87.71% / 8.60
=-10.20%

Singular Health Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-47.93% / 6.89
=-6.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -6.96% mean?
Singular Health Group (ASX:SHG) has a ROE % Adjusted to Book Value of -6.96% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Singular Health Group and its competitors.
Is Singular Health Group's ROE % Adjusted to Book Value too high?
Singular Health Group's current ROE % Adjusted to Book Value is -6.96%. Overall, Singular Health Group has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Singular Health Group's ROE % Adjusted to Book Value compare to VEEV and BTSG?
Singular Health Group's ROE % Adjusted to Book Value of -6.96% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Singular Health Group and its competitors. Singular Health Group's current ROE % Adjusted to Book Value is -6.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singular Health Group stock overvalued right now?
Based on GuruFocus' analysis, Singular Health Group (ASX:SHG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.11, compared to a current price of A$0.20 — trading 81.8% above its estimated fair value. The current ROE % Adjusted to Book Value is -6.96%. Singular Health Group's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Singular Health Group (ASX:SHG), the current ROE % Adjusted to Book Value is -6.96% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Singular Health Group (ASX:SHG) Overvalued in 2026?

Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued. The current stock price of A$0.20 is trading 81.8% above its estimated GF Value™ of A$0.11. GuruFocus considers Singular Health Group to be Significantly Overvalued.

Key valuation signals for ASX:SHG:

  • ROE % Adjusted to Book Value: -6.96%
  • GF Value™: A$0.11 vs. price of A$0.20 (81.8% above fair value)
  • GF Score™: 30/100 with 2 warning signs

No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Singular Health Group Business Description

Address E3 and E4, 661 Newcastle Street, Leederville, WA, AUS, 6007
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
30GF Score

Get the complete analysis for ASX:SHG

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.20
Price
A$0.11
GF Value